CD44 and hepatocellular carcinoma: These results are consistent with a meta-analysis reported by Luo and Tan [23], in which the authors underlined an association between CD44 expression and higher tumor TNM stage, as well as poor overall survival (OS) for patients with HCC, which strongly suggests that CD44 plays a role in contributing to HCC development and progression, making it a potential prognostic factor.